✦ LIBER ✦

Value of SPET/CT image fusion in the assessment of neuroendocrine tumours with 111In-Pentetreotide scintigraphy

✍ Scribed by A. Paula Moreira; L. Hugo Duarte; F. Vieira; F. João; J. Pedroso de Lima

Book ID: 119977414
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 890 KB
Volume: 24
Category: Article
ISSN: 0212-6982
DOI: 10.1157/13070352

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S2024 Comparison of 68GA-Octreotate-PET

S2024 Comparison of 68GA-Octreotate-PET and (111in)-Pentetreotide Scintigraphy (Octreoscantm)-SPECT in Patients with Neuroendocrine Tumours

✍ Srirajaskanthan, Rajaventhan; Soh, Jade; Quigley, Ann-Marie; Toumpanakis, Christ 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Impact of111In-DTPA-octreotide SPECT/CT

Impact of111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours

✍ P. Castaldi; V. Rufini; G. Treglia; I. Bruno; G. Perotti; G. Stifano; B. Barbaro 📂 Article 📅 2008 🏛 Springer 🌐 Italian ⚖ 593 KB

Clinical value of a combined multi-phase

Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component

✍ Patrick Veit-Haibach; Marc Schiesser; Jan Soyka; Klaus Strobel; Niklaus G. Schae 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 441 KB

Value of image fusion using single photo

Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours

✍ H. Amthauer; T. Denecke; T. Rohlfing; J. Ruf; M. Böhmig; M. Gutberlet; U. Plöcki 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 208 KB

Comparison of68Ga-DOTATATE and68Ga-DOTAN

Comparison of68Ga-DOTATATE and68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours

✍ Kabasakal, Levent; Demirci, Emre; Ocak, Meltem; Decristoforo, Clemens; Araman, A 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 216 KB

A metastatic neuroendocrine anaplastic s

A metastatic neuroendocrine anaplastic small cell tumor in a patient with multiple endocrine neoplasia type 1 syndrome. Assessment of disease status and response to doxorubicin, cyclophosphamide, etoposide chemotherapy through scintigraphic imaging with 111in-pentetreotide

✍ Kenneth J. O'Byrne; Michael G. Goggins; Dermot P. Kelleher; Donald G. Weir; Geor 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

Extrapulmonary small cell and small cell neuroendocrine tumors of unknown primary site are, in general, aggressive neoplasms with a short median survival. Like small cell lung cancer (SCLC), they often are responsive to chemotherapy and radiotherapy. Small cell lung cancer and well differentiated ne